Updated: 6 hours ago
Medically reviewed by Dr Eric Wang- ChinaCureLink Team
The best HIFU treatment centre in China depends on the condition—not a universal hospital ranking. Four centres worth comparing are Chongqing Medical University’s Second Affiliated Hospital, Fudan University Shanghai Cancer Center, Third Xiangya Hospital in Changsha, and Chongqing Haifu Hospital. Each has documented focused-ultrasound services or research. For international patients, the decisive question is whether HIFU can safely reach the lesion and improve a meaningful outcome compared with standard treatment.
Key Takeaways |
• Match the centre to the diagnosis: fibroid treatment and cancer ablation require different expertise. • Chinese centres have substantial HIFU experience, but treatment volume does not prove better outcomes. • HIFU can avoid an incision; burns and injury to nearby structures remain possible. • For pancreatic cancer, HIFU is a selected local-treatment option, not a proven replacement for curative surgery or systemic therapy. • Confirm the device, indication, individual suitability and written cost estimate before travel. |
Table of Contents
What HIFU Treats—and Why the Diagnosis Comes First
High-intensity focused ultrasound concentrates sound energy inside a target, usually heating and destroying tissue while imaging guides treatment. Ultrasound-guided and MRI-guided systems differ. This guide focuses on tumor and uterine HIFU services; cosmetic HIFU and brain-focused ultrasound require separate assessments.
Fibroids are benign uterine growths; adenomyosis involves tissue within the uterine muscle. Neither is the same as uterine cancer. For cancer, local ablation treats a chosen area and does not automatically control disease elsewhere. A centre should explain whether the goal is symptom relief, local control, or part of a broader cancer plan.
What the Clinical Evidence Shows
China has contributed important clinical experience. A prospective, nonrandomized study published in BJOG in 2018 included 2,411 women at 20 Chinese hospitals: 1,353 received HIFU, 586 myomectomy, and 472 hysterectomy. Major adverse events were reported in 0.2% after HIFU versus 12.6% after surgery. Median hospital stays were four, eight, and ten days, respectively. Patients chose treatment and the groups differed substantially, so this does not establish that HIFU is safer for every patient.
For pancreatic cancer, the comparison is different. A 2024 Third Xiangya retrospective study included 89 nonmetastatic patients: 43 received HIFU and 46 surgery. Median overall survival was 10 months with HIFU versus 23 months with surgery. Selection differences prevent a causal comparison, but the study certainly does not justify replacing potentially curative surgery with HIFU. Compare pancreatic cancer hospitals in China for a full multidisciplinary assessment.
For selected unresectable cancers, HIFU may be considered for local treatment or pain relief alongside other care. Benefits remain indication-specific. Exploratory combinations with immunotherapy are research questions; one response does not establish synergy or justify an immune-cell or vaccine package.
Four HIFU Centres to Compare
These centres were selected for documented HIFU activity, primary research, or focused services. They are not ranked from best to worst. No verified HIFU-specific head-to-head outcome ranking was identified. General hospital reputation does not show which team is best for a particular lesion.
Second Affiliated Hospital of Chongqing Medical University — Chongqing
The hospital’s official profile describes a dedicated Haifu tumor-treatment centre treating benign and malignant tumors, with chemotherapy and other interventions available within the department. Its team contributed to the Chinese multicentre fibroid evidence.
Chongqing · Grade 3A public university hospital Dedicated HIFU centre · Benign and malignant tumors · Multimodal care Selection basis: dedicated HIFU tumor-treatment department Known for: A dedicated HIFU department established in 1999, with published clinical research. |
This is a public-hospital option for comparing focused ultrasound with other treatment approaches. The department lists its outpatient service at the Yuzhong campus; confirm the actual treatment site, device and indication before booking. International medical services are advertised on the hospital website, but acceptance for a particular HIFU procedure remains case-specific.
Fudan University Shanghai Cancer Center — Shanghai
Fudan’s official clinical information lists HIFU alongside microwave, radiofrequency and cryoablation for selected cancers. Its researchers published a 2023 retrospective analysis of sequential HIFU with chemotherapy in inoperable pancreatic cancer.
Shanghai · Grade 3A public cancer hospital Cancer-focused care · Pancreatic research · Multiple ablation methods Selection basis: documented cancer HIFU services and pancreatic research Known for: Published HIFU-plus-chemotherapy research in inoperable pancreatic cancer. |
That combination of cancer services and several local-treatment methods makes it relevant when the decision is whether HIFU belongs in an oncology plan. Publication does not confirm an open trial or overseas treatment slot. The guide to cancer hospitals in Shanghai provides broader local context.
Third Xiangya Hospital, Central South University — Changsha
Third Xiangya’s December 2025 report states that its gynecologic HIFU treatment volume exceeded 10,000 after starting in 2012. The hospital describes work in fibroids, adenomyosis and other selected conditions, with an international training role.
Changsha · Grade 3A public university hospital Fibroids and adenomyosis · HIFU training centre · Multidisciplinary review Selection basis: substantial gynecologic HIFU experience and clinical research Known for: A gynecologic HIFU program reporting over 10,000 treatments by December 2025. |
This is particularly relevant to patients seeking a uterus-preserving assessment. Volume is evidence of experience, not a success rate or fertility guarantee. Cancer proposals need a separate oncology review; the hospital’s own pancreatic study found longer overall survival in its surgical group.
Chongqing Haifu Hospital — A Focused Private Option — Chongqing
Chongqing Haifu Hospital lists fibroids, adenomyosis and selected solid tumors among its services. Its own March 2024 introduction reports patients from more than 20 countries and a focused-ultrasound training base. This is an institutional report, not independently audited international-outcome data.
Chongqing · Specialist hospital; Grade 3A status not verified HIFU-focused hospital · Benign uterine disease · Overseas patient experience Selection basis: HIFU-focused services and reported overseas patient experience Known for: A dedicated focused-ultrasound clinical and training setting. |
Compared with the three public centres, its principal appeal is a concentrated HIFU service. Complex cancer cases still need assessment of surgery, systemic treatment and other ablation methods. No comparative survival advantage or equivalent Grade 3A designation has been verified. For liver tumors, also compare liver cancer hospitals in China before selecting a local technique.
China Versus International Treatment Pathways
China offers experienced ultrasound-guided HIFU teams and locally developed equipment. Access elsewhere varies by indication and device. UK NICE guidance on ultrasound-guided HIFU for fibroids calls for special governance, consent, and audit or research because efficacy evidence is limited in quality. It also highlights burns, recurring symptoms, and uncertainty about future fertility and pregnancy.
Uterus preservation does not guarantee fertility. Compare HIFU with medication, myomectomy, uterine artery embolization, or hysterectomy according to symptoms and pregnancy plans. For operable pancreatic cancer, surgery remains central to the chance of long-term survival; for advanced disease, systemic treatment addresses disease beyond the ablation target.
A hospital service listing is not an approval certificate. The exact device model, Chinese registration, labeled indication, and proposed use must be checked. Clinical research and use beyond a device’s labeled indication require separate discussion. No special-access route or overseas enrollment is assumed here.
Eligibility, Costs, and International Patient Challenges
Three barriers matter most: confirming the diagnosis and treatment goal; establishing a safe ultrasound path on imaging; and arranging reliable follow-up after returning home. Bowel gas, scars, ribs, lesion depth, and proximity to bowel or nerves may restrict treatment. MRI or contrast CT, prior operation reports, and cancer pathology help the team assess suitability.
For fibroids, imaging should characterize number, location, size, and features that raise concern for malignancy. For cancer, provide stage, previous systemic therapy and radiation, and current organ function. A local HIFU plan should explain what happens to untreated sites and whether systemic treatment continues.
There is no verified all-inclusive international-patient price for these four centres in this review. An itemized quote should separate consultation, imaging, preparation, anesthesia or sedation, each treatment session, admission, medication, follow-up and possible repeat ablation. The guide to cancer treatment costs in China explains wider budgeting; it is not a HIFU hospital quote.
The four-day median fibroid admission in the BJOG cohort is historical study data, not a promised itinerary. Allow time for reassessment, preparation, treatment and observation; cancer care may require multiple visits. Review how to travel to China for medical treatment after suitability has been assessed.
Independent Guidance Before Booking
ChinaCureLink, a Medebound HEALTH company, represents the patient rather than a single hospital. Hospital and specialist matching is free. Its team can organize the diagnosis, imaging and treatment history, compare up to three suitable pathways from this wider shortlist, and help arrange a specialist video second opinion. These are paid consultations, with fees confirmed before booking.
The ChinaCureLink hospital matching process helps patients compare a proposed HIFU treatment with alternatives before committing to travel. A free advisory call does not establish medical eligibility or hospital acceptance. On-site coordination carries a separately quoted service fee when the patient proceeds.
Patients can also approach hospitals directly. Provide a concise translated summary and original DICOM scans, identify the responsible HIFU department, and obtain a written treatment scope and estimate. If an experimental combination is proposed, establish the protocol, sponsor, eligibility and expenses; the guide to clinical trials in China for foreigners covers those distinctions.
Contacting Hospitals Directly vs. ChinaCureLink
Both routes can work. The treating hospital decides medical suitability; facilitation helps organize the assessment and practical arrangements.
Practical Next Steps Before Travel
1. Confirm the diagnosis and whether the target is benign or malignant. 2. Compare appropriate treatments, including standard alternatives. 3. Shortlist centres with experience in that exact indication. 4. Obtain a video specialist opinion using the actual scans. **5. Travel only after understanding the goal, risks, full estimate and follow-up plan.
China’s HIFU experience makes these centres worth investigating, particularly for selected benign uterine disease and some local tumor-treatment needs. The most useful second opinion explains both whether HIFU is technically feasible and whether it is the best next treatment for that individual.
Get a Second Opinion
For suitable cases, ChinaCureLink can then coordinate an online consultation with the specialist to discuss the technical treatment details directly. The purpose is to help the patient understand which treatment option and which specialist center may be most appropriate before making an international treatment decision.
One Published Patient’s Response to Combined Treatment
A Chinese case report published in Frontiers in Pharmacology in January 2023 described an 80-year-old woman with metastatic pancreatic cancer treated with HIFU, gemcitabine and sintilimab, followed by additional therapies. The authors reported a partial response, 11 months of progression-free survival and about 20 months of overall survival.
The same report documented grade 3 immune colitis and immune ureteritis requiring treatment interruption and corticosteroids. The patient later progressed and died. Because several treatments were used in one patient, the contribution of HIFU cannot be isolated. This is an encouraging individual response with serious harms—not a cure or a predicted outcome. Pancreatic cancer immunotherapy in China requires its own biomarker and eligibility assessment. Seek a second opinion before travel.
Figure 2 from Ni et al. (2023) shows imaging and tumor-marker changes during combined treatment. Reproduced unaltered under CC BY; this single patient received several therapies. Primary source · CC BY 4.0
What Patients Say About ChinaCureLink & Medebound HEALTH
These are general experiences of care coordination, not evidence of HIFU treatment outcomes.
China CureLink operates under Medebound HEALTH — an internationally recognized healthcare navigation company incorporated in New York, with operations across North America and Asia-Pacific.
Frequently Asked Questions
Which Are the Best HIFU Treatment Centres in China?
Four documented options are the Second Affiliated Hospital of Chongqing Medical University, Fudan University Shanghai Cancer Center, Third Xiangya Hospital and Chongqing Haifu Hospital. They have different strengths. No verified HIFU-specific outcome ranking establishes one as best for every disease.
Can HIFU Replace Surgery or Chemotherapy for Cancer?
Usually it should be considered within a disease-specific plan. HIFU treats a local target and does not automatically treat distant cancer. For potentially resectable pancreatic cancer, a surgical assessment remains essential. A retrospective Chinese comparison found median survival of 23 months after surgery versus 10 months after HIFU; selection differences limit causal interpretation.
How Can International Patients Check HIFU Suitability and Costs?
Send recent MRI or contrast CT in DICOM format, diagnosis and pathology where relevant, prior treatment records and the treatment goal. The hospital must confirm a safe acoustic path, exact device and indication, preparation and follow-up. Obtain an itemized estimate. Hospital matching is free through ChinaCureLink; specialist video consultations and on-site services have separately confirmed fees.
About ChinaCureLink
ChinaCureLink helps patients across the world access the best cancer treatment at China's top hospitals, without the delays, language barriers, and administrative confusion that typically come with seeking care abroad.
We connect patients directly with China's top cancer hospitals, ensuring that from the first case submission through to treatment and follow-up, every step is guided, translated, and coordinated by a team experienced in cross-border patient care.
ChinaCureLink is proudly affiliated with Medebound HEALTH — founded by US physicians, with over 10 years of experience and more than 3,000 patients served worldwide, Medebound HEALTH is recognized by Forbes and it is one of the most trusted patient cross-border concierge service company across North America and the Asia Pacific.
References
Hospital photographs: Second Affiliated Hospital of Chongqing Medical University, Third Xiangya Hospital, Fudan University Shanghai Cancer Center and Chongqing Haifu Hospital; authentic institutional images, displayed crops. Reuse permissions require editorial confirmation before publication. Clinical Figure 2 © Ni et al. 2023, CC BY 4.0; unaltered and scaled.
Disclaimer
This article is for informational purposes only and is not medical or financial advice. Treatment eligibility, protocols, and costs vary by individual case — confirm specifics with a coordinator and treating physician before making any decisions.
You may also like:
